Local News CSL Behring and Seattle Children’s Research Institute to Advance Gene Therapy Treatments for Primary Immunodeficiency DiseasesBioSpace | June 3, 2020Seattle Children's Research Institute, one of the top pediatric research institutions in the world, and…emcguinnJune 3, 2020 Read More
Local News In Cancer, the Context ‘Makes’ the MutationFred Hutch | June 2, 2020In cancer, it’s tempting to divide genes into two camps: those that suppress cancer and…emcguinnJune 2, 2020 Read More
Local News CTI BioPharma Announces Enrolment of First Patient in COVID-19 PRE-VENT Phase 3 Clinical TrialCTI BioPharma Corp. | June 2, 2020CTI BioPharma Corp. today announced that it has enrolled the first patient in the Phase…emcguinnJune 2, 2020 Read More
Local News The Most Common Organism in the Oceans Harbors a Virus in its DNAUW | June 1, 2020The most common organism in the oceans, and possibly on the entire planet, is a…emcguinnJune 1, 2020 Read More
Local News Seattle Genetics Announces Positive Results from Exploratory Analyses of HER2CLIMB for TUKYSA™ (tucatinib) in Brain Metastases Patients with HER2-Positive Breast CancerSeattle Genetics | June 1, 2020Seattle Genetics, Inc. today announced positive results from exploratory analyses of intracranial efficacy, including survival,…emcguinnJune 1, 2020 Read More
Local News Are Children Making Antibodies That Will Protect Against Future COVID-19 Infections?Seattle Children's | May 29, 2020When Dr. Janet Englund (pictured), a member of the Center for Clinical Translational Research at Seattle Children’s Research Institute,…emcguinnMay 29, 2020 Read More
Local News Teaming Up with Virginia Mason for Rapid COVID-19 ResearchBenaroya Research Institute at Virginia Mason | May 29, 2020Scientists at Benaroya Research Institute at Virginia Mason (BRI) are studying COVID-19 patient blood samples…emcguinnMay 29, 2020 Read More
Local News $3.5M Grant to Develop Safer Treatment for Inherited Blood DisordersFred Hutch | May 28, 2020Millions of people worldwide suffer from inherited nonmalignant blood disorders like sickle cell disease and…emcguinnMay 28, 2020 Read More
Local News Sensei Biotherapeutics Completes Acquisition of Alvaxa Biosciences, Seattle-Based Camelid Antibody Therapeutics CompanyBusiness Wire, Inc. | May 28, 2020Sensei Biotherapeutics, Inc., a clinical-stage biopharmaceutical company developing precision immuno-oncology therapies, today announced the acquisition…emcguinnMay 28, 2020 Read More
Local News A-Alpha Bio Demonstrates Feasibility for Molecular Glue Discovery and Receives Phase II SBIR FundingA-Alpha Bio, Inc. | May 28, 2020A-Alpha Bio today announced that it has been awarded a National Science Foundation Phase II…emcguinnMay 28, 2020 Read More